Viewing StudyNCT00002213



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002213
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
Sponsor: Glaxo Wellcome
Organization: NIH AIDS Clinical Trials Information Service

Organization Data

Organization: NIH AIDS Clinical Trials Information Service
Class: INDUSTRY
Study ID: 264F
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Glaxo Wellcome
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators